New Ray Medicine International Holding Limited (HKG:6108)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.2390
-0.0010 (-0.42%)
Last updated: Feb 20, 2026, 10:18 AM HKT

Revenue by Segment

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Distribution and Trading of Pharmaceutical Products
88.71M42.85M83.75M329.62M128.69M
Distribution and Trading of Pharmaceutical Products Growth
107.01%-48.84%-74.59%156.13%12.25%
Provision of Marketing and Promotion Services of Drugs
5.24M7.30M6.02M5.76M4.52M
Provision of Marketing and Promotion Services of Drugs Growth
-28.28%21.36%4.48%27.41%13.57%
Total
93.95M50.15M89.77M335.38M133.21M
Total Growth
87.31%-44.13%-73.23%151.76%12.29%

Revenue by Geography

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
People's Republic of China (PRC)
93.95M50.15M89.77M335.38M133.21M
People's Republic of China (PRC) Growth
87.31%-44.13%-73.23%151.76%12.29%
Total
93.95M50.15M89.77M335.38M133.21M
Total Growth
87.31%-44.13%-73.23%151.76%12.29%
Source: S&P Global Market Intelligence.